Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility

Lisa M. Marinelli, John B. Kisiel, Seth W. Slettedahl, Douglas W. Mahoney, Maureen A. Lemens, Vijayalakshmi Shridhar, William R. Taylor, Julie K. Staub, Xiaoming Cao, Patrick H. Foote, Kelli N. Burger, Calise K. Berger, Maria C. O'Connell, Karen A. Doering, Maria Giakoumopoulos, Hannah Berg, Carla Volkmann, Adam Solsrud, Hatim T. Allawi, Michael KaiserAbram M. Vaccaro, Catherine Albright Crawford, Cynthia Moehlenkamp, Gracie Shea, Melissa S. Deist, J. Kenneth Schoolmeester, Sarah E. Kerr, Mark E. Sherman, Jamie N. Bakkum-Gamez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility'. Together they form a unique fingerprint.

Medicine & Life Sciences